You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for PROMETHAZINE VC PLAIN


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PROMETHAZINE VC PLAIN

Vendor Vendor Homepage Vendor Sku API Url
Starshine Chemical ⤷  Get Started Free 2023-05-7C03311 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: PROMETHAZINE VC PLAIN

Last updated: July 31, 2025

Introduction

Promethazine VC Plain is a combination pharmaceutical comprising promethazine, an antihistamine, and codeine, an opioid cough suppressant. Widely used for allergy relief, nausea, and cough suppression, its formulation demands high-quality Active Pharmaceutical Ingredient (API) sourcing to ensure efficacy, safety, and regulatory compliance. This report provides an in-depth analysis of critical bulk API sources for promethazine and codeine, emphasizing leading manufacturers, quality standards, sourcing considerations, and industry trends.

Overview of Promethazine and Codeine APIs

Promethazine API is a phenothiazine derivative with sedative, antihistaminic, and antiemetic properties. Its synthesis involves complex chemical processes requiring specialized manufacturing capabilities to achieve high purity and stability.

Codeine API, a naturally occurring alkaloid derived primarily from opium poppies (Papaver somniferum), is also synthesized chemically or extracted from opium. Regulatory oversight of codeine varies internationally, influencing its sourcing options.

Both APIs demand strict compliance with pharmacopeial standards, typically USP, EP, or JP, depending on the target markets.

Major API Suppliers for Promethazine

Global Manufacturers

  1. Jiangsu Hetero Labs Limited (India)
    A leading producer of promethazine API, Hetero Labs has a strong reputation for quality and regulatory compliance, supplying to global markets including the US, Europe, and Asia. They adhere to strict cGMP standards and have multiple certifications, including USFDA approval.

  2. Hubei Huacan Pharmaceutical Co., Ltd. (China)
    Hubei Huacan specializes in phenothiazine derivatives, including promethazine API. Their manufacturing processes comply with international quality standards, and they possess requisite certifications for export to regulated markets.

  3. Bioways Pharmaceutical (India)
    Known for its extensive portfolio of phenothiazine APIs, Bioways offers promethazine with assured purity levels, supporting formulations for allergies and sedatives.

  4. Tecnoquimicas S.A. (Colombia)
    A quality-focused supplier dedicated to Latin America and global clients, Tecnoquimicas emphasizes regulatory adherence and reliable supply chains.

Key Sourcing Considerations

  • Regulatory approvals: Prefer suppliers with USFDA, EMA, or Japanese MOH approvals.
  • Quality certifications: ISO 9001, cGMP compliance, and pharmacopeial adherence are vital indicators.
  • Supply stability: Confirm long-term supply agreements and manufacturing capacity.
  • Cost considerations: Balance between quality and competitive pricing, particularly for large bulk orders.

Major API Suppliers for Codeine

Global Manufacturers

  1. Sun Pharmaceutical Industries Ltd. (India)
    One of the world's largest generic pharmaceutical companies, Sun Pharma manufactures high-quality codeine APIs that meet international standards, including USFDA and EMA approvals. They have a robust regulatory track record.

  2. Mingxin Pharmaceutical (China)
    Mingxin offers competitively priced codeine APIs with consistent quality. They export globally, adhering to international pharmacopoeias.

  3. Siegfried AG (Switzerland)
    A prominent active pharmaceutical ingredient manufacturer with high-quality standards, Siegfried produces pharmaceutical-grade codeine for regulated markets, emphasizing purity and compliance.

  4. Hikma Pharmaceuticals (UK)
    A reputable supplier of APIs, Hikma maintains strict quality control processes, supplying codeine APIs for various formulations globally.

Opium Poppy Sourcing & Synthetic Alternatives

  • The primary raw material for natural codeine derives from Papaver somniferum. Countries like Australia, Turkey, and India dominate opium production. Regulatory controls here significantly impact supply stability.
  • Synthetic production routes for codeine have been developed but are less common due to complexity and cost, resulting in continued reliance on natural extraction.

Sourcing Challenges and Best Practices

  • Regulatory compliance: Ensure suppliers comply with controlled substance regulations per DEA (US), EMA, and other respective agencies.
  • Ethical sourcing: Confirm opium raw materials originate from certified, legally compliant sources.
  • Purity and batch consistency: Verify vendor certifications and batch testing reports.

Emerging Trends and Industry Outlook

Regulatory Environment

Global scrutiny over opioids has tightened, affecting codeine API trade flows. Countries restrict manufacturing, export, and import processes, emphasizing traceability, diversion control, and compliance.

Quality and Certification

Increasing demand for APIs adhering to pharmacopoeial standards, notably USP, EP, and JP, drives suppliers to upgrade manufacturing processes. Traceability and batch transparency have become critical differentiators.

Supply Chain Resilience

Recent disruptions due to geopolitical tensions, COVID-19, and regulatory crackdowns have prompted pharmaceutical companies to diversify their API sourcing networks, incorporating multiple suppliers to mitigate risks.

Sustainability and Ethical Sourcing

There’s a rising emphasis on sustainable opium cultivation and alternative synthetic routes for codeine, driven by regulatory pressures and socio-economic considerations.

Conclusion

Securing high-quality bulk APIs for promethazine VC Plain involves navigating a complex landscape of global manufacturers, regulatory frameworks, and supply chain risks. Leading suppliers such as Jiangsu Hetero Labs, Sun Pharma, Siegfried, and Hikma offer reliable, compliant, and quality-assured APIs. Due diligence encompasses verifying certifications, adherence to pharmacopeial standards, and transparent raw material sourcing, especially for opium-derived codeine.

Strategic procurement, focusing on supplier reputation, regulatory compliance, and supply stability, remains vital in maintaining the integrity and efficacy of promethazine VC Plain formulations.


Key Takeaways

  • Opt for suppliers with robust regulatory approval and certification histories, ensuring API quality and regulatory compliance across markets.
  • Prioritize diversified sourcing strategies to mitigate geopolitical and logistical risks, especially concerning controlled substances like codeine.
  • Engage with suppliers demonstrating transparency in raw material sourcing, adhering to ethical and legal guidelines.
  • Monitor evolving regulations governing opioids and phenothiazine derivatives, adjusting procurement strategies accordingly.
  • Invest in stringent quality assurance processes, including batch testing and quality certifications, to prevent issues related to API impurities or inconsistent potency.

FAQs

1. What are the primary factors influencing API sourcing decisions for promethazine VC Plain?
Key factors include regulatory compliance, API purity, supplier reputation, manufacturing capacity, cost, supply chain stability, and adherence to international pharmacopoeial standards.

2. How do regulatory restrictions impact the sourcing of codeine APIs?
Codeine, as a controlled substance, faces strict regulations governing its production, export, and import. Regulatory agencies enforce diversion control and licensing requirements, reducing available suppliers and complicating procurement processes.

3. Which regions dominate the production of promethazine and codeine APIs?
India and China dominate promethazine API production, leveraging advanced chemical manufacturing facilities. Opium-derived codeine's primary raw material is sourced from Australia, Turkey, and India, with synthetic alternatives still emerging.

4. How important are certifications like USFDA approval in API sourcing?
Certifications ensure compliance with strict quality standards, facilitating easier regulatory approval and reducing risks of impurities or substandard quality in finished products.

5. What are emerging trends in API sourcing for penicillin derivatives like promethazine?
Trends include increased emphasis on sustainability, traceability of raw materials, diversification of supply sources, and adherence to stricter regulatory frameworks, driven by global supply chain challenges and regulatory scrutiny.


References

[1] Pharmaceutical Technology. "API sourcing and regulation trends." 2022.
[2] European Medicines Agency. "Guidelines on control strategies and validation." 2021.
[3] US Food and Drug Administration. "Controlled Substance Regulations." 2022.
[4] MarketWatch. "Global API Market Overview." 2023.
[5] World Health Organization. "Opioid raw material supply and regulation." 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.